Citigroup’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $61.1M | Buy |
4,226,882
+2,578,335
| +156% | +$37M | 0.03% | 566 |
|
|
2025
Q4 | $23.5M | Buy |
1,648,547
+1,536,288
| +1,369% | +$15.1M | 0.01% | 1016 |
|
|
2025
Q3 | $885K | Sell |
112,259
-244,016
| -68% | -$1.74M | ﹤0.01% | 3240 |
|
|
2025
Q2 | $2.04M | Sell |
356,275
-90,164
| -20% | -$582K | ﹤0.01% | 2628 |
|
|
2025
Q1 | $3.64M | Sell |
446,439
-115,894
| -21% | -$1.07M | ﹤0.01% | 2209 |
|
|
2024
Q4 | $5.3M | Buy |
562,333
+239,493
| +74% | +$2.49M | ﹤0.01% | 1897 |
|
|
2024
Q3 | $3.45M | Buy |
322,840
+176,496
| +121% | +$1.92M | ﹤0.01% | 2170 |
|
|
2024
Q2 | $1.45M | Sell |
146,344
-586,792
| -80% | -$6.02M | ﹤0.01% | 2608 |
|
|
2024
Q1 | $8.64M | Buy |
733,136
+261,818
| +56% | +$3.35M | 0.01% | 1331 |
|
|
2023
Q4 | $6.69M | Buy |
471,318
+96,651
| +26% | +$1.1M | ﹤0.01% | 1421 |
|
|
2023
Q3 | $4.56M | Buy |
374,667
+10,303
| +3% | +$133K | ﹤0.01% | 1485 |
|
|
2023
Q2 | $4.58M | Sell |
364,364
-231,279
| -39% | -$2.74M | ﹤0.01% | 1542 |
|
|
2023
Q1 | $6.61M | Buy |
595,643
+219,224
| +58% | +$2.7M | ﹤0.01% | 1346 |
|
|
2022
Q4 | $4.6M | Sell |
376,419
-243,325
| -39% | -$2.74M | ﹤0.01% | 1512 |
|
|
2022
Q3 | $6.47M | Buy |
619,744
+32,046
| +5% | +$357K | ﹤0.01% | 1394 |
|
|
2022
Q2 | $6.31M | Buy |
587,698
+355,935
| +154% | +$2.93M | ﹤0.01% | 1393 |
|
|
2022
Q1 | $2.19M | Sell |
231,763
-277,523
| -54% | -$2.6M | ﹤0.01% | 2291 |
|
|
2021
Q4 | $5.88M | Buy |
509,286
+195,405
| +62% | +$2.18M | ﹤0.01% | 1708 |
|
|
2021
Q3 | $3M | Sell |
313,881
-191,924
| -38% | -$1.96M | ﹤0.01% | 2198 |
|
|
2021
Q2 | $4.88M | Buy |
505,805
+73,010
| +17% | +$713K | ﹤0.01% | 1908 |
|
|
2021
Q1 | $4.28M | Buy |
432,795
+335,772
| +346% | +$5.2M | ﹤0.01% | 1892 |
|
|
2020
Q4 | $2.24M | Buy |
97,023
+49,001
| +102% | +$1M | ﹤0.01% | 2743 |
|
|
2020
Q3 | $678K | Sell |
48,022
-152,035
| -76% | -$2.22M | ﹤0.01% | 3589 |
|
|
2020
Q2 | $3.02M | Sell |
200,057
-34,541
| -15% | -$421K | ﹤0.01% | 2339 |
|
|
2020
Q1 | $2.17M | Buy |
234,598
+124,622
| +113% | +$1.18M | ﹤0.01% | 2396 |
|
|
2019
Q4 | $1.07M | Sell |
109,976
-68,491
| -38% | -$627K | ﹤0.01% | 3676 |
|
|
2019
Q3 | $1.43M | Sell |
178,467
-27,741
| -13% | -$301K | ﹤0.01% | 3244 |
|
|
2019
Q2 | $2.57M | Buy |
206,208
+187,816
| +1,021% | +$2.38M | ﹤0.01% | 2574 |
|
|
2019
Q1 | $251K | Sell |
18,392
-745,496
| -98% | -$9.11M | ﹤0.01% | 4874 |
|
|
2018
Q4 | $7.32M | Sell |
763,888
-918,215
| -55% | -$10.1M | 0.01% | 1502 |
|
|
2018
Q3 | $20.3M | Buy |
1,682,103
+1,225,986
| +269% | +$17.1M | 0.02% | 827 |
|
|
2018
Q2 | $7.13M | Buy |
456,117
+419,714
| +1,153% | +$6.34M | 0.01% | 1535 |
|
|
2018
Q1 | $547K | Buy |
36,403
+23,885
| +191% | +$363K | ﹤0.01% | 3884 |
|
|
2017
Q4 | $180K | Sell |
12,518
-35,049
| -74% | -$482K | ﹤0.01% | 5149 |
|
|
2017
Q3 | $718K | Sell |
47,567
-122,685
| -72% | -$1.62M | ﹤0.01% | 3717 |
|
|
2017
Q2 | $1.71M | Buy |
170,252
+130,702
| +330% | +$1.05M | ﹤0.01% | 2749 |
|
|
2017
Q1 | $282K | Sell |
39,550
-245,040
| -86% | -$1.55M | ﹤0.01% | 4363 |
|
|
2016
Q4 | $1.42M | Buy |
284,590
+255,172
| +867% | +$1.77M | ﹤0.01% | 3328 |
|
|
2016
Q3 | $218K | Buy |
29,418
+29,286
| +22,186% | +$198K | ﹤0.01% | 4582 |
|
|
2016
Q2 | $1K | Sell |
132
-98,709
| -100% | -$690K | ﹤0.01% | 6977 |
|
|
2016
Q1 | $835K | Buy |
98,841
+67,140
| +212% | +$476K | ﹤0.01% | 3546 |
|
|
2015
Q4 | $308K | Sell |
31,701
-826,880
| -96% | -$7.45M | ﹤0.01% | 4330 |
|
|
2015
Q3 | $12M | Buy |
858,581
+857,328
| +68,422% | +$13.4M | 0.01% | 1012 |
|
|
2015
Q2 | $18K | Sell |
1,253
-12,520
| -91% | -$151K | ﹤0.01% | 6164 |
|
|
2015
Q1 | $150K | Sell |
13,773
-8,621
| -38% | -$76K | ﹤0.01% | 4750 |
|
|
2014
Q4 | $186K | Buy |
22,394
+22,302
| +24,241% | +$153K | ﹤0.01% | 4750 |
|
|
2014
Q3 | $1K | Buy |
+92
| New | +$482 | ﹤0.01% | 6900 |
|
|
2014
Q2 | – | Sell |
-5,771
| Closed | -$12K | – | 7180 |
|
|
2014
Q1 | $12K | Sell |
5,771
-8,503
| -60% | -$21.3K | ﹤0.01% | 6263 |
|
|
2013
Q4 | $33K | Sell |
14,274
-12,064
| -46% | -$26.5K | ﹤0.01% | 5929 |
|
|
2013
Q3 | $61K | Buy |
26,338
+26,101
| +11,013% | +$65.5K | ﹤0.01% | 5125 |
|
|
2013
Q2 | $0 | Buy |
+237
| New | +$728 | ﹤0.01% | 6758 |
|
Other funds holding FOLD
VCM
PCM
VPM
GCL
Citigroup's FOLD Position: Q1 2026 in Review
Citigroup increased its Amicus Therapeutics (FOLD) stake by 156% in Q1 2026, buying an estimated $37M and bringing the position to 4,226,882 shares worth $61.1M. The position accounts for 0.03% of the portfolio, ranked #566.
Citigroup first reported a position in FOLD in Q2 2013 and has held it in 51 quarters since. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.
- Citigroup held 4,226,882 shares of Amicus Therapeutics worth $61.1M as of Q1 2026.
- Citigroup bought 2,578,335 Amicus Therapeutics shares in Q1 2026, an estimated $37M.
- Amicus Therapeutics made up 0.03% of Citigroup's portfolio in Q1 2026, its #566 holding.
- Citigroup first reported a position in Amicus Therapeutics in Q2 2013 and has held it in 51 quarters since.
- 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.
Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.